HOUSTON and WALTHAM, Mass., April 17, 2025 /PRNewswire/ -- Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated ...

Landmark 12,000-patient study addresses critical gap in global healthcare: South Asian populations face heart disease at younger ages but are diagnosed with tools calibrated for Western genetics.

Drug discovery is a long and high-risk process, with the development and approval process for each new drug costing up to $2 billion on average. Biostate AI, a start-up based in Palo Alto and Houston, ...

Artificial intelligence technologies hold huge promise for the biotechnology industry, which hopes analysis of massive datasets could unlock incredible breakthroughs in disease treatment. However, in ...

The biotechnology startup has secured strategic research partnerships in the U.S. and India, and a joint venture in China, dramatically expanding the global dataset for their RNA sequencing-based ...

(MENAFN- GlobeNewsWire - Nasdaq) The company is reimagining the fragmented reality of molecular research by building the world's largest RNA sequencing dataset. This dataset will train a ...

Biostate AI collaborates globally with leading hospitals, researchers, biomedical startups and biopharma partners. Founded by David Zhang (Rice University) and Ashwin Gopinath (MIT), the company is ...

Houston, May 20, 2025 (GLOBE NEWSWIRE) -- Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by ...